BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 11292972)

  • 1. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial glucose regulation and diabetic complications.
    Ceriello A; Hanefeld M; Leiter L; Monnier L; Moses A; Owens D; Tajima N; Tuomilehto J
    Arch Intern Med; 2004 Oct; 164(19):2090-5. PubMed ID: 15505121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
    Winkler G; Baranyi E
    Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 6. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical decision making: managing postprandial hyperglycemia.
    Hurel SJ; Mohan V
    J Assoc Physicians India; 2006 Nov; 54():871-6. PubMed ID: 17249256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
    Tushuizen ME; Diamant M; Heine RJ
    Postgrad Med J; 2005 Jan; 81(951):1-6. PubMed ID: 15640422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice.
    Boutati EI; Raptis SA
    Diabetes Metab Res Rev; 2004; 20 Suppl 2():S13-23. PubMed ID: 15551342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point.
    Haffner S
    Int J Clin Pract Suppl; 2001 Sep; (123):24-6. PubMed ID: 11594293
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: counterpoint.
    Heine RJ
    Int J Clin Pract Suppl; 2001 Sep; (123):27-9. PubMed ID: 11594294
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA; Valiquette G; Schwarcz MD
    Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 16. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
    Gerich JE; Odawara M; Terauchi Y
    Curr Med Res Opin; 2007 Aug; 23(8):1791-8. PubMed ID: 17610805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus.
    Slama G
    Int J Clin Pract Suppl; 2000 Sep; (112):9-12. PubMed ID: 11064945
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications.
    Qiao Q; Tuomilehto J; Borch-Johnsen K
    Diabetologia; 2003 Mar; 46 Suppl 1():M17-21. PubMed ID: 12652354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.